Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers - GeneBOPP

NCT04330716 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT04330716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04330716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers - GeneBOPP
Lead sponsor
Dana-Farber Cancer Institute
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2020
Completion date
December 31, 2023
Enrollment
269 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastatic prostate cancer, ovarian cancer, pancreatic cancer